JP2014530801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530801A5 JP2014530801A5 JP2014517060A JP2014517060A JP2014530801A5 JP 2014530801 A5 JP2014530801 A5 JP 2014530801A5 JP 2014517060 A JP2014517060 A JP 2014517060A JP 2014517060 A JP2014517060 A JP 2014517060A JP 2014530801 A5 JP2014530801 A5 JP 2014530801A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- oral administration
- liquid
- administration according
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 9
- 239000007788 liquid Substances 0.000 claims 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 239000004310 lactic acid Substances 0.000 claims 5
- 235000014655 lactic acid Nutrition 0.000 claims 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 4
- 239000004471 Glycine Substances 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 235000011187 glycerol Nutrition 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 2
- 235000011054 acetic acid Nutrition 0.000 claims 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000001630 malic acid Substances 0.000 claims 2
- 235000011090 malic acid Nutrition 0.000 claims 2
- 239000001384 succinic acid Substances 0.000 claims 2
- 235000011044 succinic acid Nutrition 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- ZKIAIYBUSXZPLP-UHFFFAOYSA-N brexpiprazole Chemical compound C1=C2NC(=O)C=CC2=CC=C1OCCCCN(CC1)CCN1C1=CC=CC2=C1C=CS2 ZKIAIYBUSXZPLP-UHFFFAOYSA-N 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 230000000873 masking effect Effects 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161548859P | 2011-10-19 | 2011-10-19 | |
| US61/548,859 | 2011-10-19 | ||
| PCT/JP2012/077668 WO2013058411A1 (en) | 2011-10-19 | 2012-10-19 | Solution for oral administration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530801A JP2014530801A (ja) | 2014-11-20 |
| JP2014530801A5 true JP2014530801A5 (enExample) | 2015-12-03 |
| JP6077534B2 JP6077534B2 (ja) | 2017-02-08 |
Family
ID=47178263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517060A Active JP6077534B2 (ja) | 2011-10-19 | 2012-10-19 | 経口投与用液剤 |
Country Status (35)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| JP6203682B2 (ja) * | 2013-07-10 | 2017-09-27 | 共和薬品工業株式会社 | アリピプラゾール含有水性液剤 |
| WO2017095265A1 (ru) * | 2015-12-01 | 2017-06-08 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения |
| RU2633635C1 (ru) * | 2016-06-29 | 2017-10-16 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения |
| WO2017095266A1 (ru) * | 2015-12-01 | 2017-06-08 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения (варианты) |
| RU2627423C1 (ru) * | 2016-06-29 | 2017-08-08 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения |
| JP6786240B2 (ja) * | 2016-03-31 | 2020-11-18 | 小林製薬株式会社 | 粘性経口組成物 |
| WO2019075127A1 (en) * | 2017-10-10 | 2019-04-18 | Vertice Pharma, Llc | ORAL MICODRIN HYDROCHLORIDE SOLUTION AND USES THEREOF |
| WO2021029020A1 (ja) * | 2019-08-13 | 2021-02-18 | 大塚製薬株式会社 | 経口医薬組成物 |
| JP2021115288A (ja) * | 2020-01-28 | 2021-08-10 | 青葉化成株式会社 | 液状組成物および液状医療材料 |
| WO2022006298A1 (en) * | 2020-06-30 | 2022-01-06 | Vireo Systems, Inc. | Compositions for controlling odor and itch and methods of and devices for administering same |
| WO2022006205A1 (en) | 2020-06-30 | 2022-01-06 | Vireo Systems, Inc. | Compositions and methods for treatment of vaginal infections |
| CN115192548A (zh) * | 2021-04-13 | 2022-10-18 | 上海博志研新药物技术有限公司 | 一种布瑞哌唑口溶膜组合物、其制备方法及应用 |
| CN115414322A (zh) * | 2022-07-05 | 2022-12-02 | 杭州民生药物研究院有限公司 | 一种富马酸卢帕他定口服液体制剂及其制备工艺 |
| CN116966140A (zh) * | 2023-08-18 | 2023-10-31 | 四川阿赛斯生物科技有限公司 | 一种含有布瑞哌唑的口服溶液及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1420077A (en) * | 1972-04-14 | 1976-01-07 | Unilever Ltd | Process for imparting or enhancing fresh cheese flavour in a food digital transmission systems |
| DE69918105T2 (de) * | 1998-04-29 | 2005-07-07 | Sumitomo Pharmaceuticals Co., Ltd. | Orale zubereitung enthaltend einen biguanid und eine organische säure |
| MY129350A (en) * | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
| US7439251B2 (en) * | 2002-05-03 | 2008-10-21 | Israel Institute For Biological Research | Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| CA2564180A1 (en) * | 2004-04-22 | 2005-11-03 | Dainippon Sumitomo Pharma Co., Ltd. | Pharmaceutical preparation containing bacterial cell wall skeleton component |
| JP4315393B2 (ja) * | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| WO2006134864A1 (ja) * | 2005-06-13 | 2006-12-21 | Dainippon Sumitomo Pharma Co., Ltd. | 可溶化型製剤 |
| EP1948133B1 (en) * | 2005-09-01 | 2011-06-29 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Argatroban formulation comprising an acid as solubilizer |
| CA2659390A1 (en) * | 2006-07-31 | 2008-02-07 | Asubio Pharma Co., Ltd. | Liquid preparation |
| CN101854915A (zh) * | 2007-09-17 | 2010-10-06 | 先灵公司 | 含细胞周期蛋白-依赖性激酶抑制化合物的制剂及使用其治疗肿瘤的方法 |
| BRPI0816412A2 (pt) | 2007-09-21 | 2017-05-16 | Forest Laboratories Holdings Ltd | forma de dosagem, e, método para tratar uma infecção bacteriana |
| US8263652B2 (en) * | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| PH12012502076A1 (en) * | 2010-08-24 | 2013-02-04 | Otsuka Pharma Co Ltd | Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative |
| CN102119922A (zh) * | 2011-03-03 | 2011-07-13 | 天津市炜杰科技有限公司 | 以酸作为增溶剂的21(s)阿加曲班静脉注射液 |
| JOP20120083B1 (ar) * | 2011-04-05 | 2021-08-17 | Otsuka Pharma Co Ltd | توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns |
-
2012
- 2012-10-18 AR ARP120103877A patent/AR088372A1/es not_active Application Discontinuation
- 2012-10-18 TW TW106124366A patent/TWI679977B/zh active
- 2012-10-18 TW TW101138422A patent/TWI632921B/zh active
- 2012-10-18 JO JOP/2012/0316A patent/JO3190B1/ar active
- 2012-10-19 EA EA201490812A patent/EA201490812A1/ru unknown
- 2012-10-19 KR KR1020147013277A patent/KR101856283B1/ko active Active
- 2012-10-19 MY MYPI2014700955A patent/MY169096A/en unknown
- 2012-10-19 US US14/352,479 patent/US20140303183A1/en not_active Abandoned
- 2012-10-19 RS RS20160549A patent/RS54967B1/sr unknown
- 2012-10-19 MX MX2014004529A patent/MX347309B/es active IP Right Grant
- 2012-10-19 LT LTEP12784753.1T patent/LT2768508T/lt unknown
- 2012-10-19 PT PT127847531T patent/PT2768508T/pt unknown
- 2012-10-19 ES ES12784753.1T patent/ES2583137T3/es active Active
- 2012-10-19 DK DK12784753.1T patent/DK2768508T3/en active
- 2012-10-19 ME MEP-2016-143A patent/ME02459B/me unknown
- 2012-10-19 PH PH1/2014/500816A patent/PH12014500816A1/en unknown
- 2012-10-19 CN CN201711285346.0A patent/CN107823131A/zh active Pending
- 2012-10-19 CN CN201280051524.2A patent/CN103889426A/zh active Pending
- 2012-10-19 CA CA2851999A patent/CA2851999C/en active Active
- 2012-10-19 SI SI201230656A patent/SI2768508T1/sl unknown
- 2012-10-19 EP EP12784753.1A patent/EP2768508B1/en active Active
- 2012-10-19 HR HRP20160989TT patent/HRP20160989T1/hr unknown
- 2012-10-19 SG SG11201401273SA patent/SG11201401273SA/en unknown
- 2012-10-19 WO PCT/JP2012/077668 patent/WO2013058411A1/en not_active Ceased
- 2012-10-19 HU HUE12784753A patent/HUE028869T2/en unknown
- 2012-10-19 BR BR112014009330A patent/BR112014009330A2/pt not_active Application Discontinuation
- 2012-10-19 EA EA202190445A patent/EA202190445A2/ru unknown
- 2012-10-19 JP JP2014517060A patent/JP6077534B2/ja active Active
- 2012-10-19 UA UAA201405162A patent/UA111506C2/uk unknown
- 2012-10-19 PL PL12784753.1T patent/PL2768508T3/pl unknown
- 2012-10-19 AU AU2012326978A patent/AU2012326978B2/en active Active
-
2014
- 2014-04-07 IL IL231988A patent/IL231988A/en active IP Right Grant
- 2014-04-11 ZA ZA2014/02669A patent/ZA201402669B/en unknown
- 2014-04-15 CL CL2014000967A patent/CL2014000967A1/es unknown
- 2014-04-15 IN IN2987DEN2014 patent/IN2014DN02987A/en unknown
- 2014-05-13 CO CO14102721A patent/CO6950486A2/es unknown
-
2016
- 2016-01-21 US US15/003,347 patent/US20160213665A1/en not_active Abandoned
- 2016-07-18 CY CY20161100695T patent/CY1117794T1/el unknown
- 2016-09-29 SM SM201600341T patent/SMT201600341B/it unknown
-
2017
- 2017-02-24 US US15/441,881 patent/US20170182036A1/en not_active Abandoned
- 2017-08-11 AU AU2017213570A patent/AU2017213570A1/en not_active Abandoned
-
2018
- 2018-05-25 US US15/989,294 patent/US20180271858A1/en not_active Abandoned
-
2019
- 2019-09-10 US US16/566,178 patent/US20200171023A1/en not_active Abandoned
-
2020
- 2020-11-13 US US17/097,168 patent/US20210236483A1/en not_active Abandoned
-
2023
- 2023-03-27 US US18/190,839 patent/US20240009186A1/en not_active Abandoned
-
2024
- 2024-08-01 US US18/791,730 patent/US20250099460A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011201907A5 (enExample) | ||
| EA201490812A1 (ru) | Раствор для перорального введения | |
| JP2015527402A5 (enExample) | ||
| JP2014534222A5 (enExample) | ||
| JP2015098469A5 (enExample) | ||
| JP2013513612A5 (enExample) | ||
| JP2014129360A5 (enExample) | ||
| ZA201508924B (en) | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition | |
| JP2016539921A5 (enExample) | ||
| FI4374878T3 (fi) | Karbetosiinia käsittävä farmaseuttinen koostumus | |
| EA201291089A1 (ru) | Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций | |
| WO2013089394A3 (ko) | 고분자 나노입자 수용액 조성물 및 그 제조방법 | |
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| WO2014144295A4 (en) | Ceftolozane antibiotic compositions | |
| JP2015007136A5 (enExample) | ||
| RU2012113844A (ru) | Пероральные суспензионные лекарственные формы ацетата эсликарбазепина | |
| JP2018154613A5 (enExample) | ||
| FR2999086B1 (fr) | Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation | |
| HRP20200829T1 (hr) | Farmaceutski pripravak u obliku oralne suspenzije koja uključuje flavonoidnu frakciju i ksantansku gumu | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| AR085273A1 (es) | Formulacion liquida libre de propelente que comprende una droga antimuscarinica | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| CN103126074B (zh) | 一种可降低卷烟主流烟气中酚类化合物的纸质滤棒滤芯基材添加剂及应用 | |
| WO2015093847A8 (en) | Liquid formulation comprising montelukast or pharmaceutically acceptable salt thereof and method for preparing same | |
| WO2010119300A9 (en) | Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone |